Navigation Links
Antibiotics for acute uncomplicated lower respiratory tract infection

According to the article published in The Journal of the American Medical Association, no offer or delayed offer of antibiotics for // acute uncomplicated lower respiratory tract infection (LRTI) is acceptable. Acute lower respiratory tract infection is a common complaint in the out patient departments and is one of the most common condition which is treated.

The randomized controlled trial was undertaken to assess the effectiveness on symptoms, beliefs, and behavior of three different antibiotic prescribing strategies and to assess the effectiveness of an information leaflet compared with brief verbal information alone. 807 patients who presented to the primary care setting between 1998 and 2003 with acute uncomplicated lower respiratory tract infection (LRTI) were randomly allocated into one of the six groups consisting of leaflet or no leaflet in the groups- immediate antibiotics, no offer of antibiotics, and delayed antibiotics. The outcome of the trial was measured in terms of symptom duration and severity. Seventy percent of them returned completed diaries and about 10% provided information on the symptom duration and severity. Cough rated as at least "a slight problem" lasted a mean of 11.7 days.

The results of the trial showed that the information leaflet had no effect on the main outcomes. Compared with no offer of antibiotics, other strategies did not alter cough duration or other primary outcomes. Compared with the group for whom immediate antibiotics were prescribed, fewer patients in the delayed and control groups used antibiotics, fewer patients were "very satisfied” and fewer patients believed in the effectiveness of antibiotics. The study concluded that no or a delayed offer of antibiotics for acute uncomplicated lower respiratory tract infection is quite acceptable. It was also associated with little difference in symptom resolution and is likely to reduce antibiotic use and beliefs in the effectiveness of antibiotics.
LRTI being a seasonal and a common problem encountered in individuals and especially in the children, the present study reveals some interesting findings in terms of antibiotic use and abuse.

Description According to the article published in The Journal of the American Medical Association, no offer or delayed offer of antibiotics for acute uncomplicated lower respiratory tract infection (LRTI) is acceptable.
'"/>




Related medicine news :

1. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
2. Antibiotics Helps Autism
3. Antibiotics losing their power against acne
4. Antibiotics help heart patients
5. Antibiotics May Help Prevent Strokes
6. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
7. Antibiotics Overload For Kids Questioned
8. The Use Of Antibiotics Questioned
9. The Dangers Of Prescribing Antibiotics
10. Eliminating Eye Infection With Antibiotics
11. Eliminating Eye Infection With Antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in the health care ... leaders in the nursing and health care industry. It also provides insight to the ... University. , As the nursing industry is coming out of one of the ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at a ... to wait until March 2017 for an interest rate increase, according to Rajeev Dhawan ... Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest to ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
(Date:5/25/2016)... May 25, 2016 As illustrated ... earlier this month, the numbers and momentum of cannabis ... climb into the billions, more research and development push ... Edition State of Legal Marijuana Markets Report  from from ... firm, much of the increase in sector is attributed ...
(Date:5/25/2016)... , May 25, 2016 ... H1 2016"market research report that provides an overview ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
Breaking Medicine Technology: